| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Verso Corporation (NYSE:VRS) ("Verso") announced that, at a special meeting of stockholders held today, its stockholder...
Pulled from Benzinga Pro data, Verso (NYSE:VRS) posted Q4 earnings of $13.00 million, an increase from Q3 of 77.59%. Sales drop...
Verso (NYSE:VRS) reported its Q4 earnings results on Monday, February 28, 2022 at 06:30 AM. Here's what investors need ...
Verso (NYSE:VRS) reported quarterly sales of $328.00 million which beat the analyst consensus estimate of $298.41 million by 9....
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth ...
Verso (NYSE:VRS) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to k...
Verso (NYSE:VRS) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to k...
Verso Corporation (NYSE:VRS) ("Verso") today announced the filing of a definitive proxy statement for a special meeting...